Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers
ContributorsThe PharmaCog Consortium
CollaboratorsMarizzoni, Moira; Frisoni, Giovanni
Published inJournal of Alzheimer's Disease, vol. 69, no. 1, p. 3-14
Publication date2019
Abstract
Keywords
- Alzheimer's disease
- Biomarkers
- Clinical trial
- Magnetic resonance imaging
- Mild cognitive impairment
- Precision medicine
Affiliation entities
Research groups
Citation (ISO format)
The PharmaCog Consortium. Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease: Structural Brain Biomarkers. In: Journal of Alzheimer’s Disease, 2019, vol. 69, n° 1, p. 3–14. doi: 10.3233/JAD-180152
Main files (1)
Article (Published version)
Identifiers
- PID : unige:116115
- DOI : 10.3233/JAD-180152
- PMID : 29914031
Journal ISSN1387-2877
